Past performance on predictions (positive or negative) is no guarantee of similar performance in the future. That goes for me as well as everyone else.
So, PPHM submitted the “unscrambled” phase-2 data to the FDA after all, and now they say they will conduct a phase-3 trial. Is this an accomplishment worthy of trumpeting? That the share price is down 75% from when the phase-2 screw-up was revealed should give you some indication of the answer.
Market Data 
Markets 
AI
